Type of residual symptom and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine

Huaiyu Yang*, Sarah Chuzi, Lara Sinicropi-Yao, Dan Johnson, Ying Chen, Alisabet Clain, Lee Baer, Patrick J. McGrath, Jonathan W. Stewart, Maurizio Fava, George I. Papakostas

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'Type of residual symptom and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine'. Together they form a unique fingerprint.

Medicine & Life Sciences